tetano
Editor, Senior Moderator
Perfusion. 2011 May 10. [Epub ahead of print]
First application of a new portable, miniaturized system for extracorporeal membrane oxygenation.
M?ller T, Philipp A, Lubnow M, Weingart C, Pfeifer M, Riegger GA, Schmid C.
Source
Department of Medicine II, University Medical Center Regensburg, Regensburg, Germany.
Abstract
Extracorporeal assist systems for respiratory and circulatory failure are increasingly used in intensive care medicine.Important technical innovations over the past years have resulted in improved biocompatibility and, consequently,reduced complication rates. Extracorporeal membrane oxygenation (ECMO) technology experienced a surge of useduring the influenza A (H1N1) pandemic, but transport of unstable patients with life-threatening ARDS is still hazardous.We describe the first successful application of a newly developed, compact and easily portable ECMO device in a patientwith severe ARDS due to influenza A (H1N1). Support with the miniaturized ECMO resulted in immediate improvementof gas exchange and a highly protective ventilation. Inspiratory pressure was decreased from 40 to 29 cmH(2)O and tidalvolume per kilogram of predicted bodyweight could be reduced from 6.5 to 3.3 mL. Small and efficient heart-lung assist systems will become a tool of growing importance in intensive care medicine, bothfor profound respiratory and cardiac failure in the future. The reduced weight and compact design of the device greatlyfacilitates transport and handling of unstable patients on ECMO.
PMID:
21558298
[PubMed - as supplied by publisher]
http://www.ncbi.nlm.nih.gov/pubmed/21558298
First application of a new portable, miniaturized system for extracorporeal membrane oxygenation.
M?ller T, Philipp A, Lubnow M, Weingart C, Pfeifer M, Riegger GA, Schmid C.
Source
Department of Medicine II, University Medical Center Regensburg, Regensburg, Germany.
Abstract
Extracorporeal assist systems for respiratory and circulatory failure are increasingly used in intensive care medicine.Important technical innovations over the past years have resulted in improved biocompatibility and, consequently,reduced complication rates. Extracorporeal membrane oxygenation (ECMO) technology experienced a surge of useduring the influenza A (H1N1) pandemic, but transport of unstable patients with life-threatening ARDS is still hazardous.We describe the first successful application of a newly developed, compact and easily portable ECMO device in a patientwith severe ARDS due to influenza A (H1N1). Support with the miniaturized ECMO resulted in immediate improvementof gas exchange and a highly protective ventilation. Inspiratory pressure was decreased from 40 to 29 cmH(2)O and tidalvolume per kilogram of predicted bodyweight could be reduced from 6.5 to 3.3 mL. Small and efficient heart-lung assist systems will become a tool of growing importance in intensive care medicine, bothfor profound respiratory and cardiac failure in the future. The reduced weight and compact design of the device greatlyfacilitates transport and handling of unstable patients on ECMO.
PMID:
21558298
[PubMed - as supplied by publisher]
http://www.ncbi.nlm.nih.gov/pubmed/21558298